ACE and myeloid sarcoma: Another study on a large cohort of 438 untreated patients with MS observed that age-adjusted CSF ACE levels were modestly decreased in purely relapsing and chronic progressive MS patients when compared with a control group consisting of 276 patients with non-inflammatory neurological disorders.